medline.ch Respirationstrakt Neoplasie

	Biaxially rotational noncoplanar radiotherapy vs. coplanar radiotherapy: A planning study for non-small-cell lung cancer. Med Dosim Tomoda R, Aoyama T, Kitagawa T, Hashimoto S, Koide Y, Tachibana H, Kodaira T. PMID: 42034522 [PubMed - as supplied by publisher]
	Clinical trajectory of KRAS G12C-mutated advanced non-small cell lung cancer: a single-center cohort study in Japan. Respir Investig Okazaki Y, Yoshioka H, Ikoma T, Araki K, Makihara N, Kitagawa M, Nagata Y, Fujii K, Okuno Y, Kamisako K, Nakanishi K, Ikeda Y, Yoshida K, Nakahama K, Takeyasu Y, Katsushima U, Yamanaka Y, Ikeda S, Kurata T. PMID: 42034368 [PubMed - as supplied by publisher]
	Predictive value of delta-radiomic features for the prognosis of patients with stage IA lung adenocarcinoma. Clin Imaging Zhong F, Li W, Lu Q, Wu L, Fang Y, Yu P, Zhao S. PMID: 42034079 [PubMed - as supplied by publisher]
	Patterns of Infection and Their Impact on Survival in Lung Cancer Patients: A Retrospective Study From Saudi Arabia. J Epidemiol Glob Health Abdalla H, Abaalala R, Alsaadoun N, Robaidi H, Dirar Q, Abdelfattah SI, Alkattan K, Shibl AM. PMID: 42033628 [PubMed - as supplied by publisher]
	CAR immune cell therapy strategies and advances for lung cancer. Discov Oncol Zheng S, Chen Y, Li R, Peng S. PMID: 42033595 [PubMed - as supplied by publisher]
	Mechanobiology of non-small cell lung cancer: bridging tumor mechanics and therapeutic strategies. Mol Biol Rep Joshi RD, Patil DN, Yadav KS. PMID: 42033548 [PubMed - indexed for MEDLINE]
	Efficacy of Osimertinib in Patients With Postoperative Recurrent Non-Small-Cell Lung Cancer Harboring Sensitizing EGFR Mutations. Thorac Cancer Iida Y, Kenmotsu H, Mori K, Morita M, Sekikawa M, Yabe M, Doshita K, Miura K, Kodama H, Morikawa N, Mamesaya N, Kobayashi H, Ko R, Wakuda K, Ono A, Naito T, Murakami H, Ohde Y, Gon Y, Takahashi T. PMID: 42033063 [PubMed - indexed for MEDLINE]
	Peripheral blood inflammatory markers as predictive and prognostic indicators in neoadjuvant immunotherapy for non-small cell lung cancer. Zhong Nan Da Xue Xue Bao Yi Xue Ban Peng Y, Zeng Y, Zhang Y, Fan D, Wang S, Deng C, Ma F, Qiu Z, Chen C, Hu Y, Hu C, Liu W, Wu F. PMID: 42032980 [PubMed - indexed for MEDLINE]
	Empirical Osimertinib as a Second-Line Treatment Is a Viable Option Following First- and Second-Generation TKI Therapy With Unknown EGFR Status in Treated Non-Small Cell Lung Cancer: A Retrospective Study. Cancer Med Lin MH, Chu KA, Chen CF, Jiang YC, Hong WC, Hung MY, Hsu CH. PMID: 42032945 [PubMed - indexed for MEDLINE]
	First-line treatments for metastatic non-small-cell lung cancer with sugemalimab plus chemotherapy: a China-based cost-effectiveness analysis. Immunotherapy Zhang Z, Meng K, Wu M, Li A, Yi Y, Shi C, Wan X, Tan C, Jiang Z. PMID: 42032906 [PubMed - as supplied by publisher]
	Uterine angiosarcoma diagnosed solely by endometrial biopsy and the effect of oral progesterone treatment on associated lung metastases. BMJ Case Rep Abu Shamleh R, Das N, Lutchman Singh K. PMID: 42031396 [PubMed - indexed for MEDLINE]
	Pseudocellulitis in a patient with non-small cell lung cancer on carboplatin, pemetrexed and pembrolizumab. BMJ Case Rep Beadman T, Chan MM. PMID: 42031384 [PubMed - indexed for MEDLINE]
	Deulorlatinib (TGRX-326) in ALK gene fusion positive non-small cell lung cancer after failure of second-generation inhibitors (DRAGON): a single-arm, multicenter, phase 2 trial. J Thorac Oncol Huang J, Chen G, Wang Z, Jin W, Zhao Y, Zhang Y, Zhuang W, Xin Y, Wang Y, Zhou J, Sun L, Jin B, Zhang G, Yao W, Yi T, Du X, Ning F, Chang J, Guo Y, Hu Y, Wang C, Ouyang W, Cai Z, Han B, Meng R, Ding Z, Su H, Li X, Yu X, Chen M, Li G, Zhang Y, Wang J, Ma R, Gong B, Cao C, Wu B, Lei C, Cao J, Zhao Y, Zhou T, Zhao S, Huang Y, Zhang L, Yang Y. PMID: 42031067 [PubMed - as supplied by publisher]
	A delta-based multi-omics model to predict adaptive radiotherapy benefit in patients with non-small cell lung cancer during carbon-ion radiotherapy. Phys Med Biol Ju Z, Kubo N, Meng X, Sakai M, Tashiro M, Ohno T. PMID: 42031010 [PubMed - as supplied by publisher]
	SSX1 and TRIM58 expression stratifies lung squamous cell carcinoma by tumor immune microenvironment characteristics and informs potential immunotherapy responsiveness. Clin Transl Oncol Zhao X, Liu C, Sun J, Wang C, Shen Q, Zhang X, Liu D, Xie J, Yang X, Liu D. PMID: 42030005 [PubMed - as supplied by publisher]
	The Association Between Inflammatory Scores and Frailty Severity: An Exploratory Retrospective Analysis in Non-Small-Cell Lung Cancer Surgical Patients. Med Sci (Basel) Iacobescu RA, Boiculese VL, Dodi G, Lunguleac T, Grigorescu C, Antoniu S. PMID: 42029594 [PubMed - indexed for MEDLINE]
	Diagnostic Challenge of a Vascular Liver Tumor With Pulmonary Hemorrhagic Metastases: A Case Report. Cureus N P H, Edakkattu AFK. PMID: 42028496 [PubMed]
	Role of radiotherapy in the treatment of EGFR-mutant non-small-cell lung cancer: a narrative review. Ther Adv Med Oncol Wang Q, Sun F, Wu M, Liu Z, Lu S, Xiao R, Xie X, Chen M, Sun X, Xing X, Wei B, Yu J, Chen D. PMID: 42028225 [PubMed]
	Targeting TROP-2 in treatment-resistant non-small cell lung cancer harboring the KRAS G12C mutation and TROP-2 upregulation: A case report. Oncol Lett Sun L, Xiong Y, Li X, Peng Y. PMID: 42027638 [PubMed]
	A transformer-based patient-agnostic tumor motion tracking model (TransTracking): A feasibility study in radiotherapy for lung cancer. Med Phys Abuduxiku M, Chai N, An X, Li Y, Wang J, Luo Y, Wu W, Liu Y, Hu Y, Li Q, He P. PMID: 42027140 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 159082

Seite 1 von 7955



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung